Ignite Creation Date:
2024-05-06 @ 6:03 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05520567
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2022-08-26
Brief Title:
A Study of Gilteritinib Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia
Sponsor:
Astellas Pharma Global Development Inc
Organization:
Astellas Pharma Inc